• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

PHTI Report: Virtual OUD Solutions are Effective, But Don’t Substantially Reduce Costs

by Fred Pennic 09/16/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– A new evaluation from the Peterson Health Technology Institute (PHTI) has assessed the effectiveness of virtual solutions for opioid use disorder (OUD). 

– The report reveals that while these solutions are as effective as traditional, in-person care, they only provide a modest improvement in patient outcomes and do not appear to be significantly expanding access to treatment.

Modest Clinical Benefits, Unclear Economic Impact

According to the PHTI evaluation, virtual OUD solutions help patients stay in treatment an average of 13 more days over six months compared to usual care. Treatment retention is considered a critical factor for clinical effectiveness, as patients who remain in care have a lower risk of fatal overdose and fewer emergency department visits and hospital admissions. While any additional time in treatment is beneficial, the report suggests that this modest improvement is not enough to substantially reduce overall healthcare spending. In fact, digital wraparound solutions, which are added to usual care, may even increase costs because the price of the solution can exceed the savings from improved treatment retention.

PHTI evaluated two main categories of virtual OUD solutions:

  • Medication-focused solutions: These solutions offer virtual prescribing, primarily for buprenorphine, with optional support services. PHTI found that these solutions can be a substitute for traditional care, with comparable or slightly lower costs for payers due to a reduction in hospitalizations and emergency room visits.
  • Digital wraparound solutions: These solutions are added to existing treatment programs and offer services such as contingency management and peer support. The evaluation found that these solutions increase net spending for purchasers because their cost is higher than the avoided healthcare costs from improved retention.

The Access Gap and Recommendations for the Future

Despite the expectation that virtual solutions would increase the number of people in medication-based OUD treatment, the assessment found no evidence that these solutions are disproportionately enrolling new patients. Currently, virtual solutions primarily reach individuals who are already in some form of treatment or would have sought in-person care.

To address this and other ongoing challenges, the PHTI report provides several recommendations:

  • Advance the evidence: More research is needed to determine which aspects of virtual OUD solutions are most effective and for which patient populations.
  • Expand access: Innovators should focus on strategies to engage and bring more untreated patients into care and keep them in treatment longer.
  • Modernize policy: Policymakers should modernize teleprescribing and licensure rules to enable these programs to expand into underserved areas. This includes finalizing proposed DEA rules for a special teleprescribing registration for controlled substances.
  • Leverage opioid settlement funds: States and localities can use opioid abatement funds to invest in virtual OUD solutions and support evidence generation.

“When it comes to opioid use disorder, any additional time in treatment helps patients avoid relapse and overdose risk. Virtual solutions perform as well as or slightly better than traditional care models, but healthcare providers and digital solutions need to continue striving for interventions that deliver more substantial improvements in retention and effectiveness,” said Caroline Pearson, executive director of PHTI. “In the meantime, the biggest impact for these solutions is to expand adoption to previously untreated patients who can benefit from proven medications and desperately need the help.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |